Intravenous anti-D treatment for immune thrombocytopenic purpura

Rh immune globulin: an interfering substance in compatibility testing.

Immunohematology·2019

DEL phenotype.

Immunohematology·2017

Bloody Brilliant: A History of Blood Groups and Blood Groupers.

Immunohematology·2017

Immunosuppressive protocols for transplantation and certain hematologic malignancies can prevent the primary immune response to the D blood group antigen.

Immunohematology·2013

Laboratory methods for Rh immunoprophylaxis: a review.

Immunohematology·2011

Nonhemolytic passenger lymphocyte syndrome: donor-derived anti-M in an M+ recipient of a multiorgan transplant.

Immunohematology·2009

Neutrophil-dependent interferonopathy contributes to joint damage in hemophilia.

Blood·2026

Recombinant ADAMTS13 in congenital thrombotic thrombocytopenic purpura: final analysis from a randomized phase 3 trial.

Blood·2026

The stress-sensing MARCH5 axis governs blood cancer apoptotic resilience via tractable protein-protein interactions.

Blood·2026

Rare Hematopoietic Stem Cells resilient to infection-induced stress sense yet withstand inflammation.

Blood·2026

How I Treat Pediatric Hematology-Oncology Patients from Families Identifying as Jehovah's Witnesses.

Blood·2026

Technical Considerations in the choice and use of ctDNA for Large B-cell lymphoma (LBCL).

Blood·2026

Predicting Antibody-Antigen Mutation ΔΔG via Side-Specific Protein Language Models and Paired Geometric Graph Learning.

Journal of chemical information and modeling·2026

Short-term outcomes of Solaris self-expanding covered stent in iliac artery occlusive disease: a single-center retrospective cohort.

Diagnostic and interventional radiology (Ankara, Turkey)·2026

Generation of T cell containing adipose tissue organoids.

iScience·2026

Quality of life and anorectal function in rectal cancer patients undergoing immunotherapy-based total neoadjuvant therapy: a comparison of organ preservation and radical surgery.

Clinical and translational radiation oncology·2026

A Literature Review of Immunotherapeutics in the Management of Adult B-Cell Acute Lymphoblastic Leukemia.

Blood and lymphatic cancer : targets and therapy·2026

Comparison of intestinal histopathological changes following teclistamab, BCMA-directed CAR T, CD19-directed CAR T and rituximab therapies.

Histopathology·2026

Related Experiment Videos

Intravenous anti-D treatment for immune thrombocytopenic purpura

Related Concept Videos

Rh immune globulin: an interfering substance in compatibility testing.

DEL phenotype.

Bloody Brilliant: A History of Blood Groups and Blood Groupers.

Immunosuppressive protocols for transplantation and certain hematologic malignancies can prevent the primary immune response to the D blood group antigen.

Laboratory methods for Rh immunoprophylaxis: a review.

Nonhemolytic passenger lymphocyte syndrome: donor-derived anti-M in an M+ recipient of a multiorgan transplant.

Neutrophil-dependent interferonopathy contributes to joint damage in hemophilia.

Recombinant ADAMTS13 in congenital thrombotic thrombocytopenic purpura: final analysis from a randomized phase 3 trial.

The stress-sensing MARCH5 axis governs blood cancer apoptotic resilience via tractable protein-protein interactions.

Rare Hematopoietic Stem Cells resilient to infection-induced stress sense yet withstand inflammation.

How I Treat Pediatric Hematology-Oncology Patients from Families Identifying as Jehovah's Witnesses.

Technical Considerations in the choice and use of ctDNA for Large B-cell lymphoma (LBCL).

Predicting Antibody-Antigen Mutation ΔΔG via Side-Specific Protein Language Models and Paired Geometric Graph Learning.

Short-term outcomes of Solaris self-expanding covered stent in iliac artery occlusive disease: a single-center retrospective cohort.

Generation of T cell containing adipose tissue organoids.

Quality of life and anorectal function in rectal cancer patients undergoing immunotherapy-based total neoadjuvant therapy: a comparison of organ preservation and radical surgery.

A Literature Review of Immunotherapeutics in the Management of Adult B-Cell Acute Lymphoblastic Leukemia.

Comparison of intestinal histopathological changes following teclistamab, BCMA-directed CAR T, CD19-directed CAR T and rituximab therapies.

Related Experiment Videos

Intravenous anti-D treatment for immune thrombocytopenic purpura

Related Concept Videos

Related Articles